1 |
Berruti A, Dogliotti L, Bitossi R, et al (2000). Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. J Urol, 164, 1248-53.
DOI
ScienceOn
|
2 |
Brown JE, Cook RJ, Lipton A, et al (2000). Costa L, Coleman RE. Prognostic factors for skeletal complications from metastatic bone disease in breast cancer. Breast Cancer Res Treat, 123, 767-79.
|
3 |
Chen YC, Sosnoski DM, Mastro AM (2010) .Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res, 12, 215.
DOI
|
4 |
Chirgwin JM, Guise TA (2000). Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit Rev Eukaryot Gene Expr, 10, 159-78.
|
5 |
Coleman RE (2006). Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res, 12, 6243-49
DOI
|
6 |
Coleman RE (1997). Skeletal complications of malignancy. Cancer, 80, 1588-94.
DOI
|
7 |
D'Silva NJ, Summerlin DJ, Cordell KG, et al (2006). Metastatic tumors in the jaws: a retrospective study of 114 cases. J Am Dent Assoc, 137, 1667-72.
DOI
|
8 |
Feller L, Kramer B, Lemmer J (2011). A short account of metastatic bone disease. Cancer Cell Int, 11, 24.
DOI
|
9 |
Reddi AH, Roodman D, Freeman C, Mohla SJ (2003). Mechanisms of tumor metastasis to the bone: challenges and opportunities. Bone Miner Res, 18, 190-4.
DOI
|
10 |
Tsuya A, Fukuoka M (2008). Bone metastases in lung cancer. Clin Calcium, 18, 455-9.
|
11 |
Virk MS, Lieberman JR (2007). Tumor metastasis to bone. Arthritis Res Ther, 9, 5.
|
12 |
Yavas O, Hayran M, Ozisik Y, Tumori (2007). Factors affecting survival in breast cancer patients following bone metastasis. Tumori, 93, 580-6.
|